Cite
HARVARD Citation
Brożyna, A. et al. (2017). TRPM1 (melastatin) expression is an independent predictor of overall survival in clinical AJCC stage I and II melanoma patients. Journal of cutaneous pathology. pp. 328-337. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Brożyna, A. et al. (2017). TRPM1 (melastatin) expression is an independent predictor of overall survival in clinical AJCC stage I and II melanoma patients. Journal of cutaneous pathology. pp. 328-337. [Online].